Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes.

The use of amino acids labeled with stable isotopes represents a relatively new approach for determining kinetic parameters of apolipoprotein metabolism; thus, several aspects of experimental protocols need to be defined. The aims of the present study were to determine whether a) different amino acid tracers or b) different methods of tracer administration affected apolipoprotein (apo) B kinetic parameters obtained by multicompartmental modeling, and c) to compare very low density lipoprotein (VLDL)-apoB metabolic parameters determined by multicompartmental modeling with those estimated by linear regression or by monoexponential analysis. [1-13C]leucine and [15N]glycine were given either as bolus injections or as primed constant infusions. A bolus of one amino acid was administered simultaneously with a primed constant infusion (8 h) of the other amino acid into four healthy normolipidemic subjects (age 23.0 +/- 1.4 yr; BMI 20.9 +/- 0.9 kg.m-2). VLDL-, intermediate density lipoprotein (IDL)-, and low density lipoprotein (LDL)-apoB enrichments were followed over 110 h. For subsequent analysis these values were converted to tracer/tracee ratios. Using the multicompartmental model, the fractional catabolic rate (FCR) for VLDL-apoB was estimated to be 0.36 +/- 0.09 h-1 after the administration of the tracer as a primed constant infusion and 0.35 +/- 0.07 h-1 when the tracer was administered as a bolus. The values for VLDL-apoB production were 14.6 +/- 6.5 mg.kg-1.d-1 and 14.1 +/- 5.4 mg.kg-1.d-1, respectively. The corresponding values for LDL-apoB were 0.027 +/- 0.016 h-1 (0.026 +/- 0.018 h-1) for the FCR and 10.5 +/- 3.7 mg.kg-1.d-1 (10.4 +/- 3.8 mg.kg-1.d-1) for the production following administration of the tracer as a primed constant infusion and a bolus, respectively. Approximately 47% of VLDL-apoB ultimately reached the LDL fraction via the VLDL-IDL-LDL pathway. Thirty-five percent of LDL-apoB did not originate from this cascade pathway, but was shunted from a rapidly turning over VLDL compartment directly into the LDL fraction. While there was some variation between individuals, VLDL-apoB and LDL-apoB parameters derived from the bolus and the primed constant infusions showed no significant differences and were closely correlated. Metabolic parameters were also independent of the two amino acids tested. Although values for FCRs of VLDL-apoB obtained from linear regression (0.36 +/- 0.19 h-1) or monoexponential analysis (0.50 +/- 0.36 h-1) did not differ significantly from those obtained by the multicompartmental model, there was considerable variation and no significant correlation in a given individual.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  J. Cortner,et al.  Measurement of (C13)arginine incorporation into apolipoprotein B-100 in very low density lipoproteins and low density lipoproteins in normal subjects using (13C)sodium bicarbonate infusion and isotope ratio mass spectrometry. , 1990, Biomedical & environmental mass spectrometry.

[2]  M. Berman,et al.  The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL. , 1980, Journal of lipid research.

[3]  B V Howard,et al.  Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins. , 1985, The Journal of clinical investigation.

[4]  E. Schaefer,et al.  Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. , 1990, The Journal of clinical investigation.

[5]  S. Grundy,et al.  Lipoprotein Kinetics and Modeling , 1982 .

[6]  C Cobelli,et al.  Models to interpret kinetic data in stable isotope tracer studies. , 1987, American Journal of Physiology.

[7]  P. Nestel,et al.  Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects. , 1991, Journal of lipid research.

[8]  R. Lees,et al.  Assay of total plasma apolipoprotein B concentration in human subjects. , 1974, The Journal of clinical investigation.

[9]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[10]  S. Grundy,et al.  Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein. , 1990, Journal of lipid research.

[11]  R. Wootton,et al.  Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. , 1980, European journal of clinical investigation.

[12]  S. Eisenberg,et al.  Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. , 1978, Journal of lipid research.

[13]  S. Grundy,et al.  13 – Kinetics of Apolipoprotein B in Normal and Hyperlipidemic Man: Review of Current Data , 1982 .

[14]  S. Grundy,et al.  Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. , 1985, The Journal of clinical investigation.

[15]  J. Cortner,et al.  Direct measurement of apolipoprotein B synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry. , 1986, Journal of lipid research.

[16]  D M Foster,et al.  Evidence for kinetic heterogeneity among human low density lipoproteins. , 1986, Metabolism: clinical and experimental.

[17]  C. Cobelli,et al.  On optimality of the impulse input for linear system identification , 1988 .

[18]  F. Moore,et al.  Blood volume measurement: a critical study prediction of normal values: controlled measurement of sequential changes: choice of a bedside method. , 1965, Advances in surgery.

[19]  J. Cortner,et al.  Measurement of apolipoprotein B synthesis in perfused rat liver using stable isotopes: [15N]hippurate as a measure of the intracellular [15N]glycine precursor enrichment. , 1989, Journal of lipid research.

[20]  D. Bier,et al.  [Incorporation of 15N in VLDL and LDL: in vivo synthesis of apolipoprotein B in the post-absorptive and fasting state]. , 1989, Klinische Wochenschrift.

[21]  D. Bilheimer,et al.  On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. , 1973, Biochimica et biophysica acta.

[22]  D. Matthews,et al.  Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. , 1982, Metabolism: clinical and experimental.

[23]  Y. Arad,et al.  Nonuniform radiolabeling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B. , 1990, Journal of lipid research.

[24]  C. Packard,et al.  Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. , 1984, The Journal of clinical investigation.

[25]  D. M. Foster,et al.  Zinc metabolism in humans: a kinetic model , 1979 .

[26]  B. Lewis,et al.  Quantitative studies of ver low densit lipoprotein: conversion to low densit lipoprotein in normal controls and primar hperlipidaemic states and the role of direct secretion of low densit lipoprotein in heterozgous familial hpercholesterolaemia , 1980, European journal of clinical investigation.

[27]  D. Matthews,et al.  Determination of stable isotopic enrichment in individual plasma amino acids by chemical ionization mass spectrometry. , 1979, Analytical chemistry.

[28]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[29]  D. Kipnis,et al.  Incorporation of 75Se-Selenomethionine into Human Apoproteins: III. Kinetic Behavior of Isotopically Labeled Plasma Apoprotein in Man , 1976, Diabetes.

[30]  R. F. Adams Determination of amino acid profiles in biological samples by gas chromatography. , 1974, Journal of chromatography.

[31]  I. Karl,et al.  The alpha-keto acids of branched-chain amino acids: simplified derivatization for physiological samples and complete separation as quinoxalinols by packed column gas chromatography. , 1980, Analytical biochemistry.

[32]  J. Ordovás,et al.  Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. , 1990, Journal of lipid research.

[33]  D. B. Zilversmit,et al.  Direct determination of human and rabbit apolipoprotein B selectively precipitated with butanol-isopropyl ether. , 1984, Journal of lipid research.

[34]  D. J. Millward,et al.  Regulation of leucine metabolism in man: a stable isotope study. , 1981, Science.